The rounds this investor is named on, who it invests beside, and where it shows up.
Named on one round in the feed.
We provide early-stage capital to the next generation of awesome life science entrepreneurs and the platform where they can realize their visions.
Venture capitalSan Francisco, CA, USAmissionbiocapital.comSince 2026-09-29
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Breye Therapeutics ApS A clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases | Series A Verified against 2 sources | $76.8M | 2026-09-29 | [ LEAD ] |